Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: A 1H MRS study Journal Article
| Authors: | Qi, J.; Fong, Y.; Saltz, L.; D'Angelica, M. I.; Kemeny, N. E.; Gonen, M.; Shia, J.; Shukla-Dave, A.; Jarnagin, W.; Do, R. K. G.; Schwartz, L. H.; Koutcher, J. A.; Zakian, K. L. |
| Article Title: | Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: A 1H MRS study |
| Abstract: | Hepatic steatosis is a hallmark of chemotherapy-induced liver injury. We made serial 1H MRS measurements of hepatic lipids in patients over the time course of a 24-week chemotherapeutic regimen to determine whether 1H MRS could be used to monitor the progression of chemotherapy-induced steatosis. Thirty-four patients with stage III or IV colorectal cancer receiving 5-fluorouracil, folinic acid and oxaliplatin (n=21) or hepatic arterial infusion of floxuridine with systemic irinotecan (n=13) were studied prospectively. 1H MRS studies were performed at baseline and after 6 and 24weeks of treatment. A 1H MR spectrum was acquired from the liver during a breath hold and the ratio of fat to fat+water (FFW) was calculated to give a measure of hepatic triglycerides (HTGCs). The methodology was histologically validated in 18 patients and the reproducibility was assessed in 16 normal volunteers. Twenty-seven patients completed baseline, 6-week and 24-week 1H MRS examinations and one was censored. Thirteen of 26 patients (50%) showed an increase in FFW after completion of treatment. Six patients (23%) developed hepatic steatosis and two patients converted from steatosis to nonsteatotic liver. Patients whose 6-week hepatic lipid levels had increased significantly relative to baseline also had a high probability of lipid elevation relative to baseline at the completion of treatment. Serial 1H MRS is effective for the monitoring of HTGC changes during chemotherapy and for the detection of chemotherapy-associated steatosis. Six of 26 patients developed steatosis during chemotherapy. Lipid changes were observable at 6weeks. © 2012 John Wiley & Sons, Ltd. |
| Keywords: | liver; imaging; steatosis; fat; folfox |
| Journal Title: | NMR in Biomedicine |
| Volume: | 26 |
| Issue: | 2 |
| ISSN: | 0952-3480 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2013-02-01 |
| Start Page: | 204 |
| End Page: | 212 |
| Language: | English |
| DOI: | 10.1002/nbm.2837 |
| PROVIDER: | scopus |
| PMCID: | PMC3519948 |
| PUBMED: | 22961714 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 February 2013" - "CODEN: NMRBE" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work